Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
04/2012
04/17/2012US8158866 Sweet pepper hybrid 9941819
04/17/2012US8158865 Soybean variety A1015484
04/17/2012US8158864 Soybean variety A1015460
04/17/2012US8158863 Soybean variety D5214244
04/17/2012US8158861 Soybean cultivar 05KL116623
04/17/2012US8158827 Transfection reagents
04/17/2012US8158766 Genes with ES cell-specific expression
04/17/2012US8158602 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/17/2012US8158597 Modulation of diacylglycerol acyltransferase 1 expression
04/17/2012US8158593 GPR17 modulators, method of screening and uses thereof
04/17/2012US8158427 Cell culture methods and devices utilizing gas permeable materials
04/17/2012US8158426 Cell culture methods and devices utilizing gas permeable materials
04/17/2012US8158425 Cell culture scaffold containing gel having interpenetrating polymer network structure
04/17/2012US8158424 Primate pluripotent stem cells cultured in medium containing gamma-aminobutyric acid, pipecolic acid and lithium
04/17/2012US8158423 Method of making a hair
04/17/2012US8158422 Erythroid cells producing adult-type β-hemoglobin generated from human embryonic stem cells
04/17/2012US8158421 Cardiomyocyte differentiation
04/17/2012US8158420 Methods for inhibiting the differentation of proliferative telencephalic cells in vitro by addition of ATF5
04/17/2012US8158419 Transgenic non-human animals for producing chimeric antibodies
04/17/2012US8158418 Chimeric alphavirus replicon particles
04/17/2012US8158417 Recombinant cell lines for the stable and high-level production of biologically active Dkk1 protein
04/17/2012US8158386 Method for producing human antibodies with properties of agonist, antagonist, or inverse agonist
04/17/2012US8158141 Cell transplant device for treatment of corneal wound
04/17/2012US8158131 Recombinant dengue virus antigens comprising the C15 signal peptide, full-length PRM protein, and full-length E protein
04/17/2012US8158122 Mixed cell populations for tissue repair and separation technique for cell processing
04/17/2012US8158121 Cardiac muscle regeneration using mesenchymal stem cells
04/17/2012US8158120 Cardiac muscle repair or regeneration using bone marrow-derived stem cells
04/17/2012US8158118 Mesenchymal precursor cell
04/17/2012US8158107 Genes and proteins associated with angiogenesis and uses thereof
04/17/2012CA2481521C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
04/17/2012CA2431600C Molecules with extended half-lives, compositions and uses thereof
04/17/2012CA2428713C Production of medium chain length polyhydroxyalkanoates from fatty acid biosynthetic pathways
04/17/2012CA2379949C Improved keratinocyte culture and uses thereof
04/17/2012CA2378871C Design of beta-sheet proteins with specific binding properties
04/17/2012CA2377607C Neurotrophic factor receptor
04/17/2012CA2360664C Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
04/17/2012CA2347928C Cell surface molecule-induced macrophage activation
04/17/2012CA2263421C Graft prosthesis, materials and methods
04/17/2012CA2157470C Mannose or xylose based positive selection
04/12/2012WO2012048298A2 Methods and systems of growing and harvesting cells in a hollow fiber bioreactor system with control conditions
04/12/2012WO2012048276A2 Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
04/12/2012WO2012048275A2 Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
04/12/2012WO2012048170A2 Humanized animals via tissue engineering and uses therefor
04/12/2012WO2012048165A2 Injectable, pore-forming hydrogels for materials-based cell therapies
04/12/2012WO2012048099A2 Nanoparticle-loaded cells
04/12/2012WO2012048093A2 Enhanced msc preparations
04/12/2012WO2012048010A2 Compositions of adult organ stem cells and uses thereof
04/12/2012WO2012047951A2 Human lung stem cells and uses thereof
04/12/2012WO2012047852A2 Compositions and methods for modulating immunodeficiency virus transcription
04/12/2012WO2012047732A2 Antibody compositions and methods of use
04/12/2012WO2012047584A2 Macaca fascicularis ccl17
04/12/2012WO2012047583A2 Antibodies binding human collagen ii
04/12/2012WO2012047290A1 Oxygenated demineralized bone matrix for use in bone growth
04/12/2012WO2012047286A1 Device and method for delivering mechanically released cells from liposuction aspirates
04/12/2012WO2012047037A2 Embryonic stem cell-derived cardiomyocytes and cell therapy product using same as an active ingredient
04/12/2012WO2012046946A1 Human neural stem cells expressing human choline acetyltransferase, and use thereof
04/12/2012WO2012046940A1 Composition for natural killer cell differentiation containing a tox as an active ingredient
04/12/2012WO2012046836A1 Hepatitis c virus gene
04/12/2012WO2012046797A1 Cancer stem cell mass and process for production thereof
04/12/2012WO2012046745A1 Therapeutic agent for malignant tumors expressing mhc class ii
04/12/2012WO2012046730A1 Method for activating helper t cell
04/12/2012WO2012046727A1 Method for producing virus vector
04/12/2012WO2012046563A1 Monoclonal antibody which recognizes ciguatoxins ctx1b and 54-deoxy-ctx1b, and ciguatoxin detection kit using same
04/12/2012WO2012046065A2 Culture method
04/12/2012WO2012045913A1 Method for isolating cells and a cell population thereof
04/12/2012WO2012045769A1 Process for protein production
04/12/2012WO2012045756A1 Process for producing three-dimensional tissue
04/12/2012WO2012045733A1 Reversibly photoswitchable polypeptides
04/12/2012WO2012045157A1 Arih2 regulates dendritic cell activation and autoimmunity
04/12/2012WO2012022725A3 Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)
04/12/2012WO2012011144A3 Use of amino acid sequences from mycobacterium tuberculosis or corresponding nucleic acids for diagnosis and prevention of tubercular infection, diagnostic kit and vaccine therefrom
04/12/2012WO2012009538A3 Adipocyte-derived membrane extract with biological activity
04/12/2012WO2012003479A3 Methods for culturing undifferentiated cells using sustained release compositions
04/12/2012WO2011159866A3 Bone filler material
04/12/2012WO2011159572A3 Human blood-brain endothelial cells derived from pluripotent stem cells and blood-brain barrier model thereof
04/12/2012WO2011156586A3 Multilayered silk scaffolds for meniscus tissue engineering
04/12/2012WO2011154403A3 Isolation of mesenchymal stem cells
04/12/2012WO2011149762A3 Method of nociceptor differentiation of human embryonic stem cells and uses thereof
04/12/2012WO2011138786A3 Stem cell bank for personalized medicine
04/12/2012WO2011137292A3 Injectable, load-bearing cell/microbead/calcium phosphate bone paste for bone tissue engineering
04/12/2012WO2011109548A3 Microbial engineering for the production of fatty acids and fatty acid derivatives
04/12/2012US20120090054 Polypeptides having endoglucanase activity and polynucleotides encoding same
04/12/2012US20120090052 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same
04/12/2012US20120090049 Seed specific usp promoters for expressing genes in plants
04/12/2012US20120090046 Zantedeschia Variety 110067-52451
04/12/2012US20120090045 Cotton Cultivar UA-48
04/12/2012US20120090043 Targets for retrovirus associated diseases
04/12/2012US20120090042 Polypeptides Having Phytase Activity And Polynucleotides Encoding Same
04/12/2012US20120090041 Compositions and Methods for Inhibiting Endogenous Immunoglobulin Genes and Producing Transgenic Human Idiotype Antibodies
04/12/2012US20120088842 Methods for optimizing electroporation
04/12/2012US20120088841 Composition and a method of treating cns disorders and hyperpigmentation
04/12/2012US20120088839 Composition for regulating cellular senescence comprising [n-2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide
04/12/2012US20120088819 Method for enhancing expression of recombinant protein
04/12/2012US20120088818 Conformation-selective nucleic acid inhibitors of ampa glutamate receptors
04/12/2012US20120088817 Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
04/12/2012US20120088815 Modified Oligonucleotide and Its Preparation and Application
04/12/2012US20120088813 Anti viral therapy
04/12/2012US20120088812 Compositions for promoting epigenetic dna demethylation and methods of use therefore
04/12/2012US20120088757 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties
04/12/2012US20120088729 Non-glycosylated transferrin expressed in monocots
1 ... 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 ... 1827